Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Pharmacokinetics of Continuous Infusion Therapy of Factor VIII Concentrates in Hemophilia A Patients with Inhibitors,

Katsumi Nishiya, MD, PhD, Ichiro Tanaka, MD, PhD, Keiji Nogami, MD, PhD, Kenichi Ogiwara, MD, PhD, Koji Yada, MD, Tomoko Matsumoto, Midori Shima, MD, PhD

Blood (2011) 118 (21): 3320.

https://doi.org/10.1182/blood.V118.21.3320.3320

Published: 2011

Journal Articles

Mechanism of the Potent Activated Protein C Resistance of Novel Factor V Mutation with W1920R (FV Nara) Relative to R506Q (FV Leiden)

Kenichi Ogiwara, MD, PhD, Keiko Shinozawa, PhD, Keiji Nogami, MD, PhD, Tomoko Matsumoto, Katsumi Nishiya, MD, PhD, Nobuyuki Tsujii, MD, Koji Yada, MD, Katsuyuki Fukutake, MD, PhD, Midori Shima, MD, PhD

Blood (2011) 118 (21): 537.

https://doi.org/10.1182/blood.V118.21.537.537

Published: 2011

Journal Articles

Procoagulant Activity of Antifibrinolytic Agents; A Novel Hemostatic Mechanism of Tranexamic Acid and Epsilon-Aminocaproic Acid.

Kenichi Ogiwara, MD, Keiji Nogami, MD, PhD, Katsumi Nishiya, MD, PhD, Nobuyuki Tsujii, MD, Midori Shima, MD, PhD

Blood (2010) 116 (21): 1151.

https://doi.org/10.1182/blood.V116.21.1151.1151

Published: 2010

Journal Articles

Tissue Factor Pathway Inhibitor Causes Unresponsiveness to Activated Prothrombin Complex Concentrates for Hemophilia A Patients with Inhibitors.

Kenichi Ogiwara, MD, Keiji Nogami, MD, PhD, Ichiro Tanaka, MD, PhD, Katsumi Nishiya, MD, PhD, Nobuyuki Tsujii, MD, Midori Shima, MD, PhD

Blood (2010) 116 (21): 3663.

https://doi.org/10.1182/blood.V116.21.3663.3663

Published: 2010

Journal Articles

Localization of Factor VIII Interactive Site within Plasmin/Plasminogen Which Is Responsible for Plasmin-Catalyzed Activation/Inactivation of Factor VIII.

Katsumi Nishiya, MD, Keiji Nogami, M.D., Kiyotaka Okada, M.D., Osamu Matsuo, M.D., Masahiro Takeyama, M.D., Kenichi Ogiwara, M.D., Ichiro Tanaka, M.D., Akira Yoshioka, M.D., Midori Shima, M.D.

Blood (2007) 110 (11): 1759.

https://doi.org/10.1182/blood.V110.11.1759.1759

Published: 2007

Journal Articles

Mechanisms of Plasmin-Catalyzed Inactivation of the Factor VIII.

Keiji Nogami, MD, PhD, Midori Shima, MD, PhD, Tomoko Matsumoto, Katsumi Nishiya, MD, Masahiro Takeyama, MD, Kohei Tatsumi, MD, Ichiro Tanaka, MD, PhD, Akira Yoshioka, MD, PhD

Blood (2005) 106 (11): 1017.

https://doi.org/10.1182/blood.V106.11.1017.1017

Published: 2005

Journal Articles

Identification of a Plasmin-Interactive Site within the A2 Domain of the Factor VIII Heavy Chain.

Keiji Nogami, MD, PhD, Midori Shima, MD, PhD, Katsumi Nishiya, MD, Evgueni L. Saenko, PhD, Masahiro Takeyama, MD, Kohei Tatsumi, MD, Ichiro Tanaka, MD, PhD, Akira Yoshioka, MD, PhD

Blood (2005) 106 (11): 1018.

https://doi.org/10.1182/blood.V106.11.1018.1018

Published: 2005

NARROW

Pharmacokinetics of Continuous Infusion Therapy of Factor VIII Concentrates in Hemophilia A Patients with Inhibitors,

Mechanism of the Potent Activated Protein C Resistance of Novel Factor V Mutation with W1920R (FV Nara) Relative to R506Q (FV Leiden)

Procoagulant Activity of Antifibrinolytic Agents; A Novel Hemostatic Mechanism of Tranexamic Acid and Epsilon-Aminocaproic Acid.

Tissue Factor Pathway Inhibitor Causes Unresponsiveness to Activated Prothrombin Complex Concentrates for Hemophilia A Patients with Inhibitors.

Localization of Factor VIII Interactive Site within Plasmin/Plasminogen Which Is Responsible for Plasmin-Catalyzed Activation/Inactivation of Factor VIII.

Mechanisms of Plasmin-Catalyzed Inactivation of the Factor VIII.

Identification of a Plasmin-Interactive Site within the A2 Domain of the Factor VIII Heavy Chain.

Email alerts

ASH Publications

American Society of Hematology

Pharmacokinetics of Continuous Infusion Therapy of Factor VIII Concentrates in Hemophilia A Patients with Inhibitors,

Mechanism of the Potent Activated Protein C Resistance of Novel Factor V Mutation with W1920R (FV Nara) Relative to R506Q (FV Leiden)

Procoagulant Activity of Antifibrinolytic Agents; A Novel Hemostatic Mechanism of Tranexamic Acid and Epsilon-Aminocaproic Acid.

Tissue Factor Pathway Inhibitor Causes Unresponsiveness to Activated Prothrombin Complex Concentrates for Hemophilia A Patients with Inhibitors.

Localization of Factor VIII Interactive Site within Plasmin/Plasminogen Which Is Responsible for Plasmin-Catalyzed Activation/Inactivation of Factor VIII.

Mechanisms of Plasmin-Catalyzed Inactivation of the Factor VIII.

Identification of a Plasmin-Interactive Site within the A2 Domain of the Factor VIII Heavy Chain.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only